Report : Europe Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles, Dermatology, Gynecology, Angiology, Orthopedics & Rheumatology, Sports Medicine, and Others], and End User (Hospitals, Aesthetic Clinics, and Wellness Center)
At 12.4% CAGR, the Europe Carboxy Therapy Market is speculated to be worth US$ 54.07 million by 2028, says Business Market Insights
According to the Insight Partners’ research, the Europe carboxy therapy market was valued at US$ 26.78 million in 2022 and is expected to reach US$ 54.07 million by 2028, registering a CAGR of 12.4% from 2022 to 2028. Increasing demand for antiaging treatments along with surge in geriatric population and growing uptake of non-invasive aesthetic procedures are the critical factors attributed to the Europe carboxy therapy market expansion.
The frequency of people age 65 or above is likely to increase from 1 in 11 to 1 in 6 from 2019 to 2025. According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Therefore, a significant increase in the geriatric population and changing beauty standards on a regional level have increased the demand for antiaging treatments to reduce fine lines and wrinkles, which helps maintain younger-looking skin for a long time. Aging is an inevitable phenomenon, and there has been increased awareness about aesthetics, significantly increasing the demand for antiaging treatments. Additionally, an increase in the geriatric population has created the demand for various types of antiaging and skin rejuvenation treatments. Carboxy therapy ensures the maximum absorption of nutrients and provides healthy skin. Moreover, there has been increased awareness among a large population about personality and appearance, along with the surge in disposable income, which has increased the use of beauty treatments, aiding the Europe carboxy therapy market.
On the contrary, regulatory policies and safety concerns associated with carbon therapy hurdles the growth of Europe carboxy therapy market.
Based on type, the Europe carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment held 47.2% share of Europe carboxy therapy market in 2022, amassing US$ 12.65 million. It is projected to garner US$ 25.37 million by 2028 to expand at 12.3% CAGR during 2022–2028.
Based on application, the Europe carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rehumatology, sports medicine, and others. The aesthetic medicine segment held 55.3% share of Europe carboxy therapy market in 2022, amassing US$ 14.80 million. It is projected to garner US$ 29.79 million by 2028 to expand at 12.4% CAGR during 2022–2028. The aesthetic medicine segment is further sub segmented into cellulite, stretch marks, alopecia, and dark under-eye circles.
Based on end user, the Europe carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment held 49.2% share of Europe carboxy therapy market in 2022, amassing US$ 13.18 million. It is projected to garner US$ 26.47 million by 2028 to expand at 12.3% CAGR during 2022–2028.
Based on country, the Europe carboxy therapy market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 28.2% share of Europe carboxy therapy market in 2022. It was assessed at US$ 7.55 million in 2022 and is likely to hit US$ 14.99 million by 2028, exhibiting a CAGR of 12.1% during the forecast period.
Key players profiles in the Europe carboxy therapy market report are Carbossiterapia Italiana; Cosmo Pro Ltd.; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; and Mezopharma, among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: email@example.com